×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NSRX – nasus pharma ltd. ordinary shares (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NSRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/22
08:00 am
nsrx
Nasus Pharma CEO Issues 2025 Letter to Shareholders
Medium
Report
Nasus Pharma CEO Issues 2025 Letter to Shareholders
11/20
08:15 am
nsrx
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
Neutral
Report
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
11/18
08:42 am
nsrx
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed [Yahoo! Finance]
Medium
Report
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed [Yahoo! Finance]
11/18
08:00 am
nsrx
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
Medium
Report
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
11/6
08:00 am
nsrx
Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Neutral
Report
Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
10/8
08:36 am
nsrx
Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program [Yahoo! Finance]
Medium
Report
Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program [Yahoo! Finance]
10/8
08:04 am
nsrx
Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program
Low
Report
Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/22
08:15 am
nsrx
Form 6-K Nasus Pharma Ltd For: Dec 22
Medium
Report
Form 6-K Nasus Pharma Ltd For: Dec 22
11/20
08:30 am
nsrx
Form 6-K Nasus Pharma Ltd For: Nov 20
Neutral
Report
Form 6-K Nasus Pharma Ltd For: Nov 20
11/18
08:15 am
nsrx
Form 6-K Nasus Pharma Ltd For: Nov 18
Low
Report
Form 6-K Nasus Pharma Ltd For: Nov 18
11/13
09:29 am
nsrx
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Hershman Ronnie
Low
Report
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Hershman Ronnie
11/12
04:06 pm
nsrx
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Megiddo Dalia
Low
Report
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Megiddo Dalia
11/10
05:06 pm
nsrx
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Gilboa Udi
Neutral
Report
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Gilboa Udi
11/3
08:01 am
nsrx
Form 6-K Nasus Pharma Ltd For: Nov 03
Medium
Report
Form 6-K Nasus Pharma Ltd For: Nov 03
10/8
09:05 am
nsrx
Form 6-K Nasus Pharma Ltd For: Oct 08
Low
Report
Form 6-K Nasus Pharma Ltd For: Oct 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: